Paolo Macor

3.9k total citations · 1 hit paper
79 papers, 2.6k citations indexed

About

Paolo Macor is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Paolo Macor has authored 79 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 21 papers in Radiology, Nuclear Medicine and Imaging and 20 papers in Molecular Biology. Recurrent topics in Paolo Macor's work include Complement system in diseases (25 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Systemic Lupus Erythematosus Research (17 papers). Paolo Macor is often cited by papers focused on Complement system in diseases (25 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Systemic Lupus Erythematosus Research (17 papers). Paolo Macor collaborates with scholars based in Italy, United States and United Kingdom. Paolo Macor's co-authors include Francesco Tedesco, Daniele Sblattero, Paolo Durigutto, Pier Luigi Meroni, Michele Dal Bo, Giuseppe Toffoli, Roberta Bulla, Claudio Tripodo, Roberto Marzari and Fleur Bossi and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Paolo Macor

77 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy

2023 108 citations Michele Dal Bo, Paolo Macor et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paolo Macor Italy	28	1.2k	643	623	521	472	79	2.6k
Liliane Fossati‐Jimack United Kingdom	27	1.6k 1.3×	260 0.4×	444 0.7×	448 0.9×	365 0.8×	65	2.1k
Daniele Sblattero Italy	35	767 0.6×	295 0.5×	460 0.7×	1.3k 2.5×	1.0k 2.2×	127	3.8k
Don L. Siegel United States	34	607 0.5×	904 1.4×	280 0.4×	1.0k 2.0×	634 1.3×	107	3.4k
Paola Magotti United States	17	1.1k 0.9×	426 0.7×	129 0.2×	395 0.8×	120 0.3×	21	1.8k
Hartwig Kosmehl Germany	38	770 0.6×	144 0.2×	378 0.6×	1.7k 3.3×	955 2.0×	188	4.8k
Jean‐Claude Brouet France	33	1.8k 1.4×	1.3k 2.0×	643 1.0×	1.3k 2.5×	590 1.3×	81	5.3k
Arko Gorter Netherlands	40	2.2k 1.8×	260 0.4×	73 0.1×	1.4k 2.6×	698 1.5×	82	4.1k
Miguel A. Crúz United States	36	1.3k 1.0×	2.2k 3.4×	53 0.1×	612 1.2×	150 0.3×	88	3.9k
Thi‐Sau Migone United States	29	2.4k 1.9×	252 0.4×	913 1.5×	625 1.2×	611 1.3×	40	3.7k
Philip J. Gotwals United States	28	1.1k 0.9×	179 0.3×	144 0.2×	1.8k 3.4×	244 0.5×	37	4.4k

Countries citing papers authored by Paolo Macor

Since Specialization

Citations

This map shows the geographic impact of Paolo Macor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Macor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Macor more than expected).

Fields of papers citing papers by Paolo Macor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Macor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Macor. The network helps show where Paolo Macor may publish in the future.

Co-authorship network of co-authors of Paolo Macor

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Macor. A scholar is included among the top collaborators of Paolo Macor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Macor. Paolo Macor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grossi, C., Liesbet Deprez, Caterina Bodio, et al.. (2025). Antiphospholipid IgG Certified Reference Material ERM^®-DA477/IFCC: a tool for aPL harmonization?. Clinical Chemistry and Laboratory Medicine (CCLM). 63(7). 1315–1326. 1 indexed citations

Pacor, Sabrina, Silvia Pegoraro, Roberta Bulla, et al.. (2024). The proline-rich antimicrobial peptide B7-005: low bacterial resistance, safe for human cells and effective in zebrafish embryo bacteraemia model. Open Biology. 14(12). 240286–240286. 4 indexed citations

Maso, Luca De, Marcello Manfredi, Giuseppe Toffoli, et al.. (2024). Stealth-Engineered Albumin-Coated Nanoparticles for Targeted Therapy: Effective Drug Delivery and Tumor Suppression in Xenograft-Zebrafish Model. International Journal of Nanomedicine. Volume 19. 13267–13286. 9 indexed citations

Färber, Jacqueline, et al.. (2023). C9 immunostaining as a tissue biomarker for periprosthetic joint infection diagnosis. Frontiers in Immunology. 14. 1112188–1112188. 1 indexed citations

Maso, Luca De, Paolo Bertoncin, Thilo Kähne, et al.. (2023). Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles. Journal of Nanobiotechnology. 21(1). 376–376. 12 indexed citations

Grossi, C., Nagaja Capitani, Marisa Benagiano, et al.. (2023). Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome. Frontiers in Immunology. 13. 1076167–1076167. 17 indexed citations

Maso, Luca De, et al.. (2022). Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPs. Biomedicines. 10(9). 2252–2252. 6 indexed citations

Toffoli, Giuseppe, et al.. (2022). Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System. Pharmaceutics. 14(12). 2605–2605. 75 indexed citations

Macor, Paolo, Paolo Durigutto, Monica Argenziano, et al.. (2022). Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy. Haematologica. 108(7). 1861–1872. 10 indexed citations

10.

Bo, Michele Dal, et al.. (2021). Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal Model. Pharmaceutics. 13(8). 1106–1106. 10 indexed citations

11.

Ruffatti, Amelia, Marta Tonello, Paolo Macor, et al.. (2021). Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome. Blood. 137(21). 2989–2992. 7 indexed citations

12.

Cotella, Diego, Maria Felicia Soluri, Francesco Raspagliesi, et al.. (2019). High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids. OncoImmunology. 8(9). e1614856–e1614856. 27 indexed citations

13.

Dapas, Barbara, Gabriele Pozzato, Sonia Zorzet, et al.. (2019). Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells. International Journal of Pharmaceutics. 574. 118895–118895. 13 indexed citations

14.

Berth, Alexander, Jacqueline Färber, Friedemann Awiszus, et al.. (2018). The terminal complement pathway is activated in septic but not in aseptic shoulder revision arthroplasties. Journal of Shoulder and Elbow Surgery. 27(10). 1837–1844. 3 indexed citations

15.

Petitbarat, Marie, Paolo Durigutto, Paolo Macor, et al.. (2015). Critical Role and Therapeutic Control of the Lectin Pathway of Complement Activation in an Abortion-Prone Mouse Mating. The Journal of Immunology. 195(12). 5602–5607. 30 indexed citations

16.

Agostinis, Chiara, Paolo Durigutto, Daniele Sblattero, et al.. (2014). A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome. Blood. 123(22). 3478–3487. 106 indexed citations

17.

Agostinis, Chiara, Paolo Durigutto, Daniele Sblattero, et al.. (2013). A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models.. ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/). 65. 245–245. 3 indexed citations

18.

Boscolo, Sabrina, Francesca Mion, Paolo Macor, et al.. (2011). Simple scale-up of recombinant antibody production using an UCOE containing vector. New Biotechnology. 29(4). 477–484. 40 indexed citations

19.

Macor, Paolo, et al.. (2008). An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies. Current Pharmaceutical Design. 14(21). 2023–2039. 15 indexed citations

20.

Macor, Paolo & Francesco Tedesco. (2007). Complement as effector system in cancer immunotherapy. Immunology Letters. 111(1). 6–13. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact